Peter Devine

Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia.

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.

ActiveTorque Pty Ltd was established in 2006 to commercialize leading research out of the University of Queensland related to the optimization of an internal combustion engine's operation in real time. ActiveTorque's unique technology which utilizes patent-pending algorithms coupled with a contactless torque sensor allows the engine control unit to automatically compensate for manufactured and environmental conditions affect engine performance. The efficiency benefits yielded include increased performance, reduced fuel consumption and decreased emissions. The ActiveTorque technology is applicable to petrol, diesel (including bio-diesel) and hybrid vehicles.

ColoCare Holdings Pty Ltd. develops pouchless colostomy care system for colostomy patients. It products are used by colon cancer patients after surgery. The company is headquartered in Birchgrove, Australia

XeroCoat, Inc. designed and manufactured anti-reflective coatings for solar energy systems, and other glass and plastic substrates. Its products are used in photovoltaic (PV) modules, poly and mono-crystalline modules, thin film PVs, concentrating PVs, and solar thermal systems. The company was founded on June 19, 2007 and was headquartered in Redwood City, CA.

Continara is an Australian medical device company developing innovative treatments in the field of incontinence care, a major growing need of the ageing population. Continara boasts a management team rich in biomedical experience and a Board covering every facet of medical device expertise. Its flagship technology is the Continara Evacuation System, a product intended to enhance the quality of life of colostomates.

DendriMed Pty Ltd. provides drug delivery services. It is a start-up company from the University of Queensland developing a drug delivery platform combining polymer and dendrimer nanotechnologies. The company is headquartered in Brisbane, Australia.

Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia.

Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia.